The latest research showed that angiotensin-converting enzyme 2 (ACE2) was expressed in specific cholangiocytes in healthy liver tissues [20] and suggested liver injury in COVID-19 patients may not be only due to hepatocyte damage but cholangiocyte dysfunction. This evidence concerns the gene ACE2 and COVID-19.